SCHEMBL10100733

SCHEMBL10100733

CC(C)(C)C1Cc2cccnc2CC1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 2/20 0.42
DRD2 P14416 1/20 0.42
CYP2D6 P10635 5/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NAMPT P43490 1/20 0.32
GRIN1 Q05586 3/20 0.31
GRIN2B Q13224 3/20 0.31
HTR2C P28335 2/20 0.31
HRH1 P35367 2/20 0.31
ADRA1A P35348 2/20 0.31
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5021323 0.83 MAPT (0.42) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL5021316 0.83 MAPT (0.42) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL5021315 0.83 MAPT (0.42) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL14490659 0.76 DRD3 (0.44) DRD3DRD2CYP2D6GRIN1GRIN2B
SCHEMBL8259536 0.76 DRD3 (0.44) DRD3DRD2CYP2D6GRIN1GRIN2B
SCHEMBL13998641 0.76 DRD3 (0.44) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL3498480 0.76 DRD3 (0.44) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL13998639 0.76 DRD3 (0.44) DRD3DRD2CYP2D6NPC1ALDH1A1
SCHEMBL14490658 0.76 DRD3 (0.44) DRD3DRD2CYP2D6GRIN1GRIN2B
SCHEMBL5021331 0.75 DRD2 (0.51) DRD3DRD2NPC1ALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041194-A1 NITROGEN AND SULFUR-CONTAINING HETROCYCLE DERIVATIVES TRIAD MULTITECH PHARMACEUTICALS, INC. (US) 2012-02-16 US disclosed
US-20110269953-A1 Nitrogen and Sulfur-Containing Heterocycle Derivatives ARMILLI MURTY N 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041194-A1 NITROGEN AND SULFUR-CONTAINING HETROCYCLE DERIVATIVES HRH4, HNMT, TST DRD3 393/4885DRD2 307/4885CYP2D6 1578/4885
US-20110269953-A1 Nitrogen and Sulfur-Containing Heterocycle Derivatives TST, HNMT, HRH4 DRD3 445/4885DRD2 341/4885CYP2D6 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.